Q3 2019 Adamas Pharmaceuticals Inc Earnings Call
שיחת ועידה Adamas Pharmaceuticals Inc
Adamas Pharmaceuticals Inc Conference call or earnings call will be held on 07/11/2019 via an 800 number (toll-free). During the earnings conference call's session Adamas Pharmaceuticals Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Adamas Pharmaceuticals Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a pharmaceutical company that discovers and develops chrono-synchronous therapies to improve the daily lives of people affected by chronic neurologic disorders. Approximately 36 million people in the United States suffer from conditions such as Parkinson's disease, multiple sclerosis, epilepsy, and Alzheimer's disease. Currently available medicines may lead to sub-optimal symptom control in these disorders. We pioneered a platform to develop medicines for chronic neurologic disorders based upon an understanding of time-dependent biologic processes responsible for disease activity and drug response. We call these medicines chrono-synchronous therapies. These therapies synchronize the temporal pattern of disease activity with the dynamics of drug profiles we invent without disrupting the brain's master clock, e.g. circadian rhythm. We believe the lives of patients with neurologic disorders are improved when these factors operate in unison.קרא עוד שיחת ועידה